Diagnostics India News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing closer to clinics and revolutionise patient care. The claim extension of the NT-proBNP biomarker, available exclusively on the cobas® h 232 system, aims to provide faster, more efficient diagnosis and management of HF in patients with type 2 diabetes...

Roche Diagnostics India announced the launch of the Elecsys HCV Duo which is India’s first commercially available fully...

BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in India and Asia.

Mumbai (Maharashtra) [India], April 5 (ANI/NewsVoir): Cervical Cancer is India's second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. Despite being the only preventable cancers, awareness about effective and reliable screening tools remains poor.

/PRNewswire/ -- Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021...